Loading Events

« All Events

  • This event has passed.

Anti-Infectives Drug Development Summit

April 20, 2021 - April 22, 2021

Infectious diseases are one of the largest threats to global public health. The focus on the threat has never been greater, with the COVID-19 pandemic demonstrating the critical need for a more proactive approach within governments, biopharma, and investment communities to overcome the pressing issues in anti-infective drug development to combat antimicrobial resistance.

With some now considering the field as the new ‘Wall Street darling’, especially given the $1 billion launch of the AMR action fund, the Digital Anti-Infectives Drug Development Summit has arrived as the most comprehensive and industry-dedicated forum that addresses the biggest challenges in the development and commercialization of anti-infective drugs.

Bringing together 60+ senior leaders from large pharma, innovative biotech, academia and investment companies, join us this April to discuss data-driven and solution-based approaches that focus on developing high value clinical candidates, novel modalities and effective strategies, that address market sustainability and aim for superiority.

Here is a sneak peak of the world-class speaker faculty:

  • Cara Cassino, Executive Vice President of R&D & Chief Medical Officer, ContraFect
  • Kevin Outterson, Executive Director, CARB-X
  • Silas Holland, Head of External Affairs (Interim) & Director of Global Policy, Merck & The AMR Action Fund
  • David Powell, Chief Scientific Officer, Summit Therapeutics
  • Dave Ousterout, Chief Scientific Officer, Locus Biosciences
  • Angela Talley, Vice President of Clinical Development, Spero Therapeutics
  • Ercem Atillasoy, Chief Regulatory & Safety Officer, AlloVir
  • David Alterac, Chief Medical Officer, Entasis Therapeutics

Click here to learn more.
Click here to view the agenda.
Click here to register.


April 20, 2021
April 22, 2021


Virtual Event
765 Commonwealth Avenue
Boston, MA 02215 United States
+ Google Map